Doctor profile · Federal record
Dr. Manan Mehta, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Gastroenterology Physician · Fredericksburg, VA
- NPI 1295862134
- Accepts Medicare
- 25 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
405 Chatham Heights RD
Fredericksburg, VA 224052582
(540) 300-6182
fax (540) 301-2294 - Additional location
-
406 Chatham Square Office Park
Fredericksburg, VA 224052585
Credentials & registration
- NPI registered
- February 2007 — 19 yrs on file
- Profile last updated
- February 1, 2024
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Virginia #0101259771
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1295862134. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
94,893
Distinct HCPCS
10
Medicare allowed
$1,936,788
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 22,950 | 23 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 16,803 | 15 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 10,800 | 21 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 9,000 | 17 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 7,984 | 58 | $23 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,350 | 11 | $42 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 4,612 | 114 | $0 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,810 | 15 | $36 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 2,967 | 12 | $7 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 2,045 | 140 | $28 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 2,214. This provider delivers 43× the peer median.Open Payments
Industry payments received
All-time total
$188
Transactions
9
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $71.23 | |
| PFIZER INC. | 2 | $33.12 | |
| Gilead Sciences, Inc. | 1 | $27.02 | |
| Spectrum Pharmaceuticals Inc. | 1 | $21.57 | |
| ABBVIE INC. | 1 | $21.24 | |
| Coherus Biosciences Inc. | 1 | $14.13 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
173
Patients
0
Total drug cost
$1,428,597
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Procrit (Epoetin Alfa) | Brand | 31 | 0 | $154,236 |
| Abiraterone Acetate | Generic | 23 | 0 | $79,615 |
| Xgeva (Denosumab) | Brand | 21 | 0 | $65,556 |
| Lenvima (Lenvatinib Mesylate) | Brand | 17 | 0 | $416,729 |
| Imatinib Mesylate | Generic | 15 | 0 | $82,177 |
| Sorafenib (Sorafenib Tosylate) | Brand | 15 | 0 | $176,462 |
| Erlotinib Hcl | Generic | 14 | 0 | $55,334 |
| Fulphila (Pegfilgrastim-Jmdb) | Brand | 14 | 0 | $131,165 |
| Venclexta (Venetoclax) | Brand | 12 | 0 | $188,508 |
| Nyvepria (Pegfilgrastim-Apgf) | Brand | 11 | 0 | $78,814 |
Frequently asked questions
What is Dr. Manan Mehta's medical specialty?
Dr. Manan Mehta practices Hematology & Oncology Physician in Fredericksburg, VA.
Where does Dr. Manan Mehta practice?
Dr. Manan Mehta practices at 405 Chatham Heights RD, Fredericksburg, VA 224052582. Office phone: 5403006182.
What is Dr. Manan Mehta's NPI?
Dr. Manan Mehta's National Provider Identifier (NPI) is 1295862134, issued by NPPES.
Does Dr. Manan Mehta accept Medicare assignment?
Yes. Dr. Manan Mehta accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Manan Mehta commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.